Pfizer’s stock falls despite fourth-quarter revenue and earnings beat. This analyst expects to growth to accelerate.
Pfizer Inc. shares fell 1.6% Tuesday despite the drugmaker topping Wall Street’s revenue and profit estimates in its fourth-quarter results.
What's Your Reaction?






